Health Care & Life Sciences » Biotechnology | Vascular Biogenics Ltd.

Vascular Biogenics Ltd. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
10,871.00
36,783.00
37,146.00
45,254.00
54,729.00
50,482
Total Accounts Receivable
380.00
595.00
706.00
768.00
3,347.00
287
Other Current Assets
127.00
366.00
740.00
552.00
382.00
940
Total Current Assets
11,378.00
37,744.00
38,592.00
46,574.00
58,458.00
51,709
Net Property, Plant & Equipment
436.00
358.00
326.00
687.00
7,128.00
8,921
Other Assets
13.00
36.00
320.00
13.00
103.00
48
Total Assets
11,827.00
38,138.00
39,238.00
47,274.00
65,689.00
60,678
Accounts Payable
1,348.00
-
-
2,522.00
3,058.00
Other Current Liabilities
2,897.00
2,930.00
4,158.00
2,266.00
4,511.00
Total Current Liabilities
4,245.00
2,930.00
4,158.00
4,788.00
7,569.00
Long-Term Debt
31,039.00
-
-
-
-
Provision for Risks & Charges
126.00
106.00
73.00
86.00
128.00
Other Liabilities
-
-
-
-
2,092.00
Total Liabilities
35,410.00
3,036.00
4,231.00
4,874.00
9,789.00
Common Equity (Total)
23,583.00
35,102.00
35,007.00
42,400.00
55,900.00
Total Shareholders' Equity
23,583.00
35,102.00
35,007.00
42,400.00
55,900.00
Total Equity
23,583.00
35,102.00
35,007.00
42,400.00
55,900.00
Liabilities & Shareholders' Equity
11,827.00
38,138.00
39,238.00
47,274.00
65,689.00

About Vascular Biogenics

View Profile
Address
8 HaSatat Street
Modi'in JM 7178106
Israel
Employees -
Website http://www.vblrx.com
Updated 07/08/2019
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.